We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603806:SSEHANGZHOU FIRST APPLIED MATERIAL CO.,LTD. Class A Analysis

Data as of 2026-06-19 - not real-time

CN¥17.52

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hangzhou First Applied Material trades at a price that is far above its discounted cash‑flow estimate, indicating a substantial valuation premium. The company’s trailing PE is markedly higher than the industry average and its forward PE, while lower, still suggests a valuation stretch relative to earnings expectations. No dividend is paid, so income‑focused investors have little yield cushion.
Technically, the stock sits near the 20‑day moving average and just above the 50‑day average, with the 200‑day average below current levels, hinting at a modest upward bias. RSI hovers around the midpoint, and the MACD histogram shows a slight bullish tilt despite a neutral overall trend. Volume is on a downward trajectory, and the beta is low, implying limited market‑wide sensitivity, yet the recent 30‑day volatility is elevated, underscoring short‑term price swings. These mixed signals suggest caution, with valuation concerns outweighing the modest technical upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • valuation premium relative to DCF
  • neutral technical stance with slight bullish MACD
  • decreasing volume and high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • persistent overvaluation despite improving forward earnings
  • sector exposure to semiconductor equipment cycles
  • moderate regulatory and geographic uncertainties in China

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • potential earnings growth from expanding photovoltaic and electronic material lines
  • forward PE indicating a narrowing gap to fair value
  • strategic positioning in a technology‑driven industry with long‑term demand

Key Metrics & Analysis

Financial Health

Revenue Growth-6.90%
Profit Margin4.46%
P/E Ratio67.4
ROE3.90%
ROA2.02%
Debt/Equity17.05
P/B Ratio2.7
Op. Cash FlowCN¥1.8B
Free Cash FlowCN¥1.3B
Industry P/E38.1

Technical Analysis

TrendNeutral
RSI52.6
SupportCN¥14.71
ResistanceCN¥19.55
MA 20CN¥17.20
MA 50CN¥17.62
MA 200CN¥16.32
MACDBullish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Fair ValueCN¥8.27
GradeOvervalued
TypeValue

Risk Assessment

Beta0.14
Volatility69.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.